News | News By Subject | News by Disease News By Date | Search News

Migraine News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Allergan (AGN) R&D Chief: Company Forges Ahead With Migraine Treatments     5/3/2017
Allergan (AGN) Looks to Expand Beyond Botox with Oral Migraine Treatments     10/12/2016
Cambridge's CoLucid Pharma (CLCD) Rockets on Late-Stage Migraine Data     9/7/2016
Amgen (AMGN) Shows Off Mid-Stage Migraine Data, Needs to Compete With Eli Lilly (LLY), Teva (TEVA) and Alder Biopharma     6/9/2016
Alder Biopharma's Migraine Drug Meets Primary and Secondary Endpoints in Phase 2b Trial     3/28/2016
Tonix Pharma (TNXP) Craters as Headache Drug Flunks Phase II Study     2/16/2016
FDA Approves AVANIR (AVNR) New Migraine Treatment With Unique Inhalant Delivery System     2/1/2016
Heptares Lines Up a $410 Million Migraine Pact with Teva (TEVA)     11/25/2015
Allergan (AGN) Slams Down $250 Million+ for Rights to Merck & Co. (MRK)'s Migraine Drugs     7/7/2015
Amgen (AMGN)'s Migraine Drug Meets Goals in Phase II Study     5/19/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AVANIR Pharmaceuticals (AVNR)'s Migraine Treatment Will Unlikely Win Approval By Scheduled Timeline     11/7/2014
AVANIR Pharmaceuticals (AVNR)' Migraine Drug AVP-825 Meets Primary Endpoint in Phase 3 Trial     6/10/2014
OptiNose AS Presents Positive Results From Phase 3 COMPASS Study     6/10/2014

News from Around the Web
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
Amgen (AMGN) Maintains Migraine Drug Lead     9/30/2016
The Drug Industry Might Finally Have An Answer For Migraines     9/26/2016
Does Eating More Salt Prevent Migraines And Severe Headaches? Huntington Medical Research Institutes Study     8/16/2016
Emotional Abuse In Childhood Linked To Migraines In Adulthood, Yale University Study     7/14/2016
NYU Langone Medical Center Researchers Pinpoint Best Meds To Treat Migraine In The ED     6/27/2016
Can Light Help Ease The Pain Of Migraines? Texas A&M University Study     6/23/2016
Migraines Linked To Vitamin Deficiencies, Cincinnati Children's Hospital Medical Center Says Study     6/13/2016
New Drug To Prevent Migraine May Start Working In Days, Teva (TEVA) Reveals     6/9/2016
Women With Migraines More Prone To Heart Disease And Early Death, Harvard Medical School Study     6/1/2016
Green Light For Migraine Relief, Harvard Medical School Study     5/20/2016
Botox Can Be Used For Chronic Migraine, Icahn School Of Medicine At Mount Sinai Study     4/21/2016
An App A Day To Keep The Doctor Away     3/28/2016
Do Genes Link Headaches, Irritable Bowel Syndrome? Istanbul University Study     2/24/2016
Migraine With Aura Linked To Clot-Caused Strokes, University of South Carolina Study     2/18/2016

Press Releases
Amgen (AMGN) Submits Biologics License Application To The FDA For Erenumab     5/19/2017
Eli Lilly (LLY)'s Migraine Drug Hits Goals In Three Phase III Studies     5/12/2017
Alder Biopharma Presents Positive Phase IIb Study Data For Eptinezumab At 69th Annual American Academy of Neurology Meeting     5/1/2017
Amgen (AMGN), Novartis AG (NVS) Expands Migraine Drug Tie-Up     4/25/2017
Novartis AG (NVS) Expands Global Collaboration With Amgen (AMGN) To Commercialize First-In-Class AMG 334 (Erenumab) Program In Migraine Prevention In The U.S. And Canada     4/25/2017
Alder Biopharma Presents Additional Data From Eptinezumab Development Program At 69th Annual American Academy of Neurology Meeting     4/24/2017
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce Marketing Approval Of RIZAPORT For Migraines In Luxembourg     4/13/2017
Supernus (SUPN) Receives Final FDA Approval For Trokendi XR For Migraine Prophylaxis In Adults And Adolescents     4/6/2017
Upsher-Smith Laboratories Release: FDA Approves Expanded Indication For Qudexy XR (Topiramate) Extended-Release Capsules To Include Prophylaxis Of Migraine Headache In Adults And Adolescents     3/30/2017
Society Of Interventional Radiology Release: Innovative Treatment Offers Relief To Children With Frequent Migraine Headaches     3/13/2017
Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System     3/10/2017
APR Applied Pharma Research S.A. And DKSH Bring Innovative Migraine And Pain Treatment To Asian Patients     3/6/2017
American Academy of Neurology Releases To The Press The Results Of Theranica‚Äôs Pilot Clinical Study For Acute Treatment Of Migraine     3/2/2017
Bay Area's Zosano (ZSAN) Surges After Migraine Patch Hits Goals in Late-Stage Study     2/13/2017
Zosano (ZSAN) Announces Last Subject Treated In Its Migraine Pivotal Trial     1/5/2017